Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|October 1, 2000
Supplements and Featured Publications
- Antibody-Targeted Chemotherapy for the Treatment of Relapsed Acute Myeloid Leukemia
- Volume 6
- Issue 18 Suppl
Continuing Medical Education Quiz
Advertisement
Articles in this issue
almost 26 years ago
Commentary: New Research and Treatment Options for Acute Myeloid Leukemiaalmost 26 years ago
Overview: Treatment of Acute Myeloid LeukemiaAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
3
New York Experts Push for Coordinated Obesity Care Teams
4
Grocery Assistance Benefit Linked to Fewer Diabetes Complications
5